NEW YORK and PALO ALTO, Calif. , Sept. 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho" or "the Company") today announced it has signed a Letter of Intent (LOI) to acquire select assets from Turn Biotechnologies, Inc. ("Turn"), a leader in induced pluripotent stem cells (iPSC) and cellular reprogramming.

Strategic funding expected to accelerate fleet deployment to over 4,000 ASIC miners Capital provided in advance of Thumzup's pending acquisition of DogeHash LOS ANGELES , Sept. 30, 2025 /PRNewswire/ -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), a digital asset accumulator and advertising industry disruptor, announced today that it has provided DogeHash Technologies Inc. ("DogeHash") with a $2.5 million loan.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company's Thermo Fisher™ Connect Platform can integrate and future-proof laboratories. From Digital Ambition to Automated Intelligence In pharma and life sciences, digital transformation is no longer a question of if — but how fast. Many labs remain stuck in a cycle of technical debt and shado.

NEW YORK--(BUSINESS WIRE)-- #UiPathFUSION--UiPath announces collaboration with NVIDIA to help enterprises fortify existing automated workloads with AI capabilities in high-trust scenarios.

Provides Simplified Operational Support and Increased Visibility Across the Network HERNDON, Va. , Sept. 30, 2025 /PRNewswire/ -- ePlus inc.

CLEVELAND--(BUSINESS WIRE)--Olympic Steel, Inc. (Nasdaq: ZEUS), a leading national metals service center, intends to release its third-quarter 2025 financial results after the market closes on October 30, 2025. A webcast to discuss these results will be held on Friday, October 31, 2025, at 10:00 a.m. Eastern Time. Olympic Steel webcast participants include Richard T. Marabito, Chief Executive Officer; Andrew Greiff, President and Chief Operating Officer; and Richard A. Manson, Chief Financial O.

EAGLE, Idaho--(BUSINESS WIRE)--Lamb Weston Holdings, Inc. (NYSE: LW) announced today its results for the first quarter of fiscal 2026 and reaffirmed its full year financial targets for fiscal 2026. Summary of First Quarter FY 2026 Results ($ in millions, except per share) Q1 2026 Year-Over-Year Growth Rates Net sales $ 1,659.3 — % Income from operations $ 156.5 (26 )% Net income $ 64.3 (50 )% Diluted EPS $ 0.46 (48 )% Adjusted Income from Operations(1) $ 206.5 5 % Adjusted.

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Alcon's acquisition of STAAR, expired at 11:59 p.m. ET on September 29, 2025. As previously announced,.

BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.

VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces that it is building a proprietary quantum computing hardware platform to power ZenaDrone's AI drones for real time immense data applications and predictions.

SHENZHEN, China, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd.

SOLANA BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced the pricing of its previously announced underwritten public offering of 441,210 shares of its common stock at a price to the public of $4.40 per share and pre-funded warrants to purchase up to 13,335 shares of Artelo's common stock at a price to the public of $4.399 per pre-funded warrant, which represents the per share public offering price of each share …

ESCONDIDO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced that it has entered into securities purchase agreements with certain new and existing institutional investors for the purchase and sale of 2,500,000 shares of common stock at a purchase price of $5.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately $12.5 million, before deducting placement agent commissions and other offering expenses. The closing of …

PROVIDENCE, R.I., Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce that Nick Liuzza, CEO of Beeline Holdings (NASDAQ: BLNE), a technology-driven, digital mortgage platform, was recently featured in an exclusive podcast interview with Benzinga Director of Customer Success, Ryan Faloona.

~ Accretive Acquisition Marks Second of Four Acquisitions Expected through Year End ~ ~ Acquisition Expected to Be Immediately Topline and EBITDA and Cash flow Accretive ~ NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading serial acquirer in the Latin American SaaS sector, today announced it has signed a binding term sheet to acquire MK Solutions, the leading ERP for internet providers in Brazil.

HAUPPAUGE, N.Y., Sept. 30, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer and manufacturer of advanced signal-processing components for satellite, Public and Private 5G, and other communications networks, including complete 5G/6G systems, and a global distributor of IC packaging solutions, today announced its membership in the ORAN Alliance and Telecom Infra Project (TIP) organizations, both widely recognized in the ORAN 5G ecosystem that are driving the adoption of ORAN 5G globally.

Publication title: “Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer's Disease Patients” Significant improvement in self-assessed Quality of Life (QoL-AD) scores indicating a reversal of negative trajectory for Alzheimer's disease clinical trial participants was observed Using a novel Precision Medicine approach, up to ~70% of Alzheimer's disease participants benefited with unprecedented effect size Oral blarcamesine tablet, by enhancing the brain's autophagy internal clearing mechanism could alleviate significant medical and economic burden Publication available on medRxiv, in submission to a peer-reviewed medical journal NEW YORK, Sept. …

BOSTON--(BUSINESS WIRE)--CRA International, Inc. (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, is opening the application process for the FirstEnergy Pennsylvania Electric Company (FE PA) auction to procure full requirements Default Supply generation service for their Default Service Customers. The application process will lead up to the auction scheduled for November 12, 2025. The bidding process will use a descending-price clock aucti.

WATERTOWN, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for bitopertin for patients aged 12 years and older with erythropoietic protoporphyria (EPP), including X-linked protoporphyria (XLP). Disc submitted the NDA under the FDA's accelerated approval pathway using reduction of protoporphyrin IX (PPIX) as a surrogate endpoint and requested a Priority Review based on bitopertin's potential to address the …

LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders, including obstructive sleep apnea (OSA), today released previously unpublished clinical data confirming that treatment with Vivos' FDA-cleared Daytime-Nighttime Appliance (DNA) can provide children with Attention-Deficit/Hyperactivity Disorder (ADHD) and OSA significant relief and improvement in their quality of life.